ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Open Access
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Current Biology
- Vol. 10 (21) , 1359-1366
- https://doi.org/10.1016/s0960-9822(00)00781-8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG15402)
This publication has 43 references indexed in Scilit:
- The Cytotoxicity and Apoptosis Induced by 4-Tertiary Butylphenol in Human Melanocytes are Independent of Tyrosinase ActivityJournal of Investigative Dermatology, 2000
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- Caspases: Preparation and CharacterizationMethods, 1999
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- Stabilization of β-Catenin by Genetic Defects in Melanoma Cell LinesScience, 1997
- Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genesNature, 1996
- The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteinsCell, 1995
- Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell deathCell, 1995
- FADD, a novel death domain-containing protein, interacts with the death domain of fas and initiates apoptosisCell, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995